Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
FDA Oncology
Dec 3, 2023, 15:55 |
Stories
Vincent Rajkumar: How a patient with cancer came up with the idea for a randomized trial, and how listening to him saved a lot of lives
Vincent Rajkumar, Editor-in-Chief of the Blood Cancer Journal, shared on Twitter: "I would like to…
Nov 29, 2023, 16:31 |
Drugs
Vivek Subbiah: Our review on management of FGFR inhibitor toxicities
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on management of FGFR inhibitor…
Nov 28, 2023, 16:43 |
Drugs
Vivek Subbiah: Pleased to share our review on RET inhibitors
Vivek Subbiah shared on LinkedIn: "Pleased to share our review on RET inhibitors and RET inhibitor…
Nov 22, 2023, 15:39 |
Blog
Tatiana Prowell: Each time I get to the final why, I’ve articulated a core value
Tatiana Prowell posted on X/Twitter: "I’ve seen multiple tweets lately from Med-Student-Twitter and Med-Twitter and…
Nov 18, 2023, 23:57 |
Blog
Edward Cliff: Excited to share our work on accelerated approval and NCCN guidelines, out today
Edward Cliff, Fellow at Harvard Medical School and Brigham & Women’s Hospital, made the following…
Nov 18, 2023, 16:59 |
Blog
Tatiana Prowell: Bad news delivered with honesty and compassion is love
Tatiana Prowell shared a X/Twitter post by David Steensma, an Associate Professor at Harvard Medical…
Nov 18, 2023, 01:33 |
Blog
Tatiana Prowell: There have been 3 cancer drug approvals in the last 24 hrs
Tatiana Prowell, Breast Cancer Scientific Lead at the Office of Hematology and Oncology Products, US…
Nov 3, 2023, 12:29 |
Insight
Talha Badar: In view of recent approval of IDH1i in MDS brief tweetorial
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Nov 1, 2023, 18:54 |
Societies
20 Posts Not To Miss From ESMO 2023 Congress
The Annual Congress of the European Society For Medical Oncology (ESMO) took place from October…
Oct 27, 2023, 17:01 |
Drugs
Revumenib in relapsed or refractory KMT2Ar acute leukemia - Syndax Pharmaceuticals
Nicole McNeer, Senior Medical Director and Clinical Leader at Syndax Pharmaceuticals, shared a post by…
53
54
55
56
57
All:
565
Posts:
541 - 550
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube